Biosimilar Market Share Greater in Medicare Advantage Versus

Analysis shows that biosimilar uptake was up to 2-fold greater in Medicare Advantage coverage than traditional Medicare.

Related Keywords

Yoganand Chillarige , Linkedin Yoganand Chillarige , Drug Administration , Medicare Advantage , Medicare Advance , Biosimilars , Biosimilar , Medicare , Advantage , Part B , Part C , Spending , Fda , Market , Costs , Study ,